| PCNA |
PCNA: Proliferating cell nuclear antigen |
LOC642558 |
FUSIP1, FUSIP2, TASR: FUS-interacting serine-arginine-rich protein 1 |
3.34 |
Evidence |
|
| PABPC1 |
PABPC1, PAB1, PABP1, PABPC2: Polyadenylate-binding protein 1 |
C13orf8 |
IPI00414497 |
3.34 |
Evidence |
|
| SRF |
SRF: Serum response factor |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
3.34 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| CDK4 |
CDK4: Cell division protein kinase 4 |
PKN3 |
PKN3, PKNBETA: Serine/threonine-protein kinase N3 |
3.34 |
Evidence |
|
| CETP |
CETP: Cholesteryl ester transfer protein precursor |
PLTP |
PLTP: Phospholipid transfer protein precursor |
3.34 |
Evidence |
|
| CETP |
CETP: Cholesteryl ester transfer protein precursor |
CFHR1 |
CFHR1, CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, HFL1, HFL2: Complement factor H-relate |
3.34 |
Evidence |
|
| TFPI |
TFPI, LACI, TFPI1: Tissue factor pathway inhibitor precursor |
SERPINA10 |
SERPINA10, ZPI, UNQ707/PRO1358: Protein Z-dependent protease inhibitor precursor |
3.34 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
GUCA2A |
GUCA2A, GUCA2: Guanylin precursor |
3.34 |
Evidence |
|
| MYBL2 |
MYBL2, BMYB: Myb-related protein B |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
3.34 |
Evidence |
|
| MYB |
MYB: Myb proto-oncogene protein |
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
3.34 |
Evidence |
|
| ALOX5 |
ALOX5, LOG5: Arachidonate 5-lipoxygenase |
CNN2 |
CNN2: Calponin-2 |
3.34 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
PLAU |
Plasminogen activator, urokinase |
3.34 |
Evidence |
|
| SERPINF2 |
SERPINF2, AAP, PLI: Alpha-2-antiplasmin precursor |
CPB2 |
CPB2: Carboxypeptidase B2 precursor |
3.34 |
Evidence |
|
| VIM |
VIM: Vimentin |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
3.34 |
Evidence |
|
| VIM |
VIM: Vimentin |
PSEN1 |
PSEN1, AD3, PS1, PSNL1: Presenilin-1 |
3.34 |
Evidence |
|
| HCK |
IPI00029769 |
CDC42 |
IPI00016786 |
3.34 |
Evidence |
|
| PLEK |
PLEK, P47: Pleckstrin |
SMAD1 |
SMAD1, BSP1, MADH1, MADR1: Mothers against decapentaplegic homolog 1 |
3.34 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
AR |
AR, DHTR, NR3C4: Androgen receptor |
3.34 |
Evidence |
|
| SP1 |
SP1, TSFP1: Transcription factor Sp1 |
IRF7 |
IPI00298041 |
3.34 |
Evidence |
|
| KLK3 |
KLK3, APS: Prostate-specific antigen precursor |
HLA-DMB |
HLA-DMB, DMB, RING7: HLA class II histocompatibility antigen, DM beta chain prec |
3.34 |
Evidence |
|
| GSN |
GSN: Gelsolin precursor |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
3.34 |
Evidence |
O
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
AFAP |
AFAP1, AFAP: Actin filament-associated protein 1 |
3.34 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
ZYX |
ZYX: Zyxin |
3.34 |
Evidence |
|
| FYN |
FYN: Proto-oncogene tyrosine-protein kinase Fyn |
NCF4 |
IPI00297156 |
3.34 |
Evidence |
|